Literature DB >> 11413137

Characterization of selected strains of pneumococcal surface protein A.

M J Jedrzejas1, E Lamani, R S Becker.   

Abstract

Several proteins, in addition to the polysaccharide capsule, have recently been implicated in the full virulence of the Streptococcus pneumoniae bacterial pathogen. One of these novel virulence factors of S. pneumoniae is pneumococcal surface protein A (PspA). The N-terminal, cell surface exposed, and functional part of PspA is essential for full pneumococcal virulence, as evidenced by the fact that antibodies raised against this part of the protein are protective against pneumococcal infections. PspA has recently been implicated in anti-complementary function as it reduces complement-mediated clearance and phagocytosis of pneumococci. Several recombinant N-terminal fragments of PspA from different strains of pneumococci, Rx1, BG9739, BG6380, EF3296, and EF5668, were analyzed using circular dichroism, analytical ultracentrifugation sedimentation velocity and equilibrium methods, and sequence homology. Uniformly, all strains of PspA molecules studied have a high alpha-helical secondary structure content and they adopt predominantly a coiled-coil structure with an elongated, likely rod-like shape. No beta-sheet structures were detected for any of the PspA molecules analyzed. All PspAs were found to be monomeric in solution with the exception of the BG9739 strain which had the propensity to partially aggregate but only into a tetrameric form. These structural properties were correlated with the functional, anti-complementary properties of PspA molecules based on the polar distribution of highly charged termini of its coiled-coil domain. The recombinant Rx1 PspA is currently under consideration for pneumococcal vaccine development.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11413137     DOI: 10.1074/jbc.M103304200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  11 in total

1.  Both family 1 and family 2 PspA proteins can inhibit complement deposition and confer virulence to a capsular serotype 3 strain of Streptococcus pneumoniae.

Authors:  Bing Ren; Alexander J Szalai; Orlanda Thomas; Susan K Hollingshead; David E Briles
Journal:  Infect Immun       Date:  2003-01       Impact factor: 3.441

2.  A Bivalent Vaccine Based on a PB2-Knockout Influenza Virus Protects Mice From Secondary Pneumococcal Pneumonia.

Authors:  Ryuta Uraki; Zhenyu Piao; Yukihiro Akeda; Kiyoko Iwatsuki-Horimoto; Maki Kiso; Makoto Ozawa; Kazunori Oishi; Yoshihiro Kawaoka
Journal:  J Infect Dis       Date:  2015-06-29       Impact factor: 5.226

3.  Differential role of CbpA and PspA in modulation of in vitro CXC chemokine responses of respiratory epithelial cells to infection with Streptococcus pneumoniae.

Authors:  Rikki M A Graham; James C Paton
Journal:  Infect Immun       Date:  2006-09-25       Impact factor: 3.441

4.  Correlation between in vitro complement deposition and passive mouse protection of anti-pneumococcal surface protein A monoclonal antibodies.

Authors:  Naeem Khan; Raies Ahmad Qadri; Devinder Sehgal
Journal:  Clin Vaccine Immunol       Date:  2014-11-19

5.  Helper T cell epitope-mapping reveals MHC-peptide binding affinities that correlate with T helper cell responses to pneumococcal surface protein A.

Authors:  Rajesh Singh; Shailesh Singh; Praveen K Sharma; Udai P Singh; David E Briles; Susan K Hollingshead; James W Lillard
Journal:  PLoS One       Date:  2010-02-25       Impact factor: 3.240

6.  Genome-wide identification of lineage and locus specific variation associated with pneumococcal carriage duration.

Authors:  Paul Turner; Stephen D Bentley; John A Lees; Nicholas J Croucher; David Goldblatt; François Nosten; Julian Parkhill; Claudia Turner
Journal:  Elife       Date:  2017-07-25       Impact factor: 8.713

7.  PspA family distribution, antimicrobial resistance and serotype of Streptococcus pneumoniae isolated from upper respiratory tract infections in Japan.

Authors:  Muneki Hotomi; Akihisa Togawa; Masamitsu Kono; Yorihiko Ikeda; Shin Takei; Susan K Hollingshead; David E Briles; Kenji Suzuki; Noboru Yamanaka
Journal:  PLoS One       Date:  2013-03-06       Impact factor: 3.240

Review 8.  Choline Binding Proteins from Streptococcus pneumoniae: A Dual Role as Enzybiotics and Targets for the Design of New Antimicrobials.

Authors:  Beatriz Maestro; Jesús M Sanz
Journal:  Antibiotics (Basel)       Date:  2016-06-14

Review 9.  Towards Identifying Protective B-Cell Epitopes: The PspA Story.

Authors:  Naeem Khan; Arif T Jan
Journal:  Front Microbiol       Date:  2017-05-02       Impact factor: 5.640

10.  Cost analysis based on bioreactor cultivation conditions: Production of a soluble recombinant protein using Escherichia coli BL21(DE3).

Authors:  Valdemir M Cardoso; Gilson Campani; Maurício P Santos; Gabriel G Silva; Manuella C Pires; Viviane M Gonçalves; Roberto de C Giordano; Cíntia R Sargo; Antônio C L Horta; Teresa C Zangirolami
Journal:  Biotechnol Rep (Amst)       Date:  2020-02-22
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.